Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05846399 · ClinicalTrials.gov registry record · Phase 4

CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)

A Phase 4 study of Hand Injuries and Anti-bacterial Agents, sponsored by University of Missouri-Columbia.

Recruiting
Registry status
Phase 4
Development phase
72
Enrollment target
1
Study location

NCT05846399: Recruiting Phase 4 study of Hand Injuries and Anti-bacterial Agents, sponsored by University of Missouri-Columbia.

NCT05846399 is a Phase 4 study of Hand Injuries and Anti-bacterial Agents that is actively recruiting participants, run by University of Missouri-Columbia. The registered enrollment target is 72 participants, above the 28-participant average among 5 other Hand Injuries trials with a reported enrollment target (157% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05846399, a Phase 4 study of Hand Injuries and Anti-bacterial Agents, is actively recruiting participants, sponsored by University of Missouri-Columbia.

RECRUITING
Registry status
Phase 4
Development phase
72 participants
Enrollment target
1
Study location

Study Summary

Cat bites are puncture wounds that have the potential to seed bacteria deep within the joint capsule, periosteum, and bone. The hand is the most common site of bite injuries. Pasteurella multocida is the is the most common organism isolated from the mouths of cats that can cause infections after a bite. Prophylactic antibiotics are often recommended with amoxicillin-clavulanate for 3-5 days to decrease the incidence of developing an infection. However, only one randomized controlled clinical trial consisting of 12 patients has been performed to justify this course of treatment, raising the possibility that the use of antibiotics could be reduced or even eliminated. Investigators will compare different durations of prophylactic antibiotics and a placebo control for cat bites to the hand/forearm presenting to the Emergency Department, Urgent Care, Plastic Surgery Clinic using a randomized, controlled, double-blind clinical trial. Participants presenting to the University of Missouri Hospital Emergency Department, Missouri University (MU) Healthcare Urgent Care, Plastic Surgery Clinic over the next year will be offered the chance to enroll if they meet the inclusion/exclusion criteria. For inclusion, participants will be \>18 years of age, have cat bites to the hand or distal to elbow, and present within 24 hours of the cat bite injury. Participants must not present with active local or systemic infections, have received antibiotics within the past 30 days, or be immunocompromised (primary and secondary immunodeficiencies). Participants will be randomized to one of three treatment arms (placebo; amoxicillin-clavulanate 1 day; amoxicillin-clavulanate 5 days). Outcomes are the development of an infection at the location of the cat bite and/or systemic infection, adverse effects of interventions, disability assessed by Quick Disabilities of Arm, Shoulder and Hand (QuickDASH) scores, and quality of life (QOL) assessed by HAND Questionnaire (HAND-Q) scores. Infection will b

Primary Outcome

To compare the incidence of infection (skin, soft tissue, joint, bone) between each study arm to determine the effect of antibiotic prophylaxis and duration on cat bites to the hand and/or forearm within 30 days. Infections are defined by, The Centers for Disease Control and Prevention National Healthcare Safety Network.

Interventions

  • DRUG Ciprofloxacin
  • DRUG Clindamycin
  • DRUG Amoxicillin/clavulanate
  • OTHER Placebo (microcrystalline cellulose)
  • PROCEDURE Wound management

Study Locations (1)

Missouri

  • University of Missouri - Columbia

Trial Details

FieldValue
Enrollment Target 72 participants
Start Date 2023-09-07
Est. Completion 2027-08-01
Phase Phase 4
University of Missouri-Columbia

291 total trials

What NCT05846399 shows while recruiting

NCT05846399 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 72 participants, a relatively small participant target, above the 28-participant average among 5 other Hand Injuries trials with a reported enrollment target (157% higher).

The record links to 5 conditions, with Hand Injuries appearing as the primary indexed condition, and to 5 interventions - of which Ciprofloxacin is the first listed.

NCT05846399 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT05846399 about?

NCT05846399 is a clinical study titled "CAT BITE Antibiotic Prophylaxis for the Hand/Forearm (CATBITE)". Cat bites are puncture wounds that have the potential to seed bacteria deep within the joint capsule, periosteum, and bone. The hand is the most common site of bite injuries. Pasteurella multocida is the is the most common organism isolated from the mouths of cats that can cause infections after a b...

What is the current status of trial NCT05846399?

This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 72 participants. The study started on 2023-09-07. Estimated completion is 2027-08-01.

What conditions does trial NCT05846399 study?

This clinical trial studies the following conditions: Hand Injuries, Anti-bacterial Agents, Arm Injury, Infection, Bacterial, Cat Bite.

What interventions are being tested in trial NCT05846399?

The interventions under investigation include: Ciprofloxacin (DRUG), Clindamycin (DRUG), Amoxicillin/clavulanate (DRUG), Placebo (microcrystalline cellulose) (OTHER), Wound management (PROCEDURE).

Who is sponsoring clinical trial NCT05846399?

This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05846399 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hand Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02359253 · 72 participants · NA

    Robot Aided Rehabilitation - Intervention

  • NCT02962661 · 72 participants · Phase 1

    Donor Bone Marrow Derived Mesenchymal Stem Cells in Controlling Heart Failure in Patients With Cardiomyopathy Caused by Anthracyclines

  • NCT03113643 · 72 participants · Phase 1

    SL-401 in Combination With Azacitidine or Azacitidine/Venetoclax in Acute Myeloid Leukemia (AML), High-Risk Myelodysplastic Syndrome (MDS) or Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)

  • NCT03187535 · 72 participants · NA

    Effect of TEAS on PONV After Spinal Surgery

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT05846399, the US trial registry maintained by the National Library of Medicine. NCT05846399 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.